Tag: Health & Medicine

Posted on by — Leave a comment

Community-Acquired Bacterial Pneumonia Market to Witness Growth by 2032, Estimates DelveInsight | Johnson & Johnson, Pfizer Inc., Dainippon Sumitomo Pharma, Takeda Pharma

“Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the 7MM. “Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical […]

Posted on by — Leave a comment

CAR-T Cell Therapy Competitive Landscape 2023 (Updated)

DelveInsight’s, “CAR T Cell Therapy Competitive Landscape 2023” report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T – Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.   […]

Posted on by — Leave a comment

Presbyopia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Santen Pharma, Glaukos Corporation, Ocuphire

(Las Vegas, Nevada, United States)  As per DelveInsight’s assessment, globally, Presbyopia pipeline constitutes 12+ key companies continuously working towards developing 12+ Presbyopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.  The Presbyopia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on by — Leave a comment

Advanced Endometrial Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Advanced Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ Advanced Endometrial Cancer companies and 25+ pipeline drugs in the Advanced Endometrial Cancer pipeline landscape. It covers the Advanced Endometrial Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Advanced Endometrial Cancer pipeline therapeutics assessment by product […]

Posted on by — Leave a comment

Non Muscle Invasive Bladder Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Non-Muscle Invasive Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Non-Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non-Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Muscle Invasive Bladder Cancer pipeline therapeutics assessment by […]

Posted on by — Leave a comment

Pompe Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Pompe Disease pipeline constitutes 15+ key companies continuously working towards developing 20+ Pompe Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Pompe Disease Pipeline report embraces in-depth commercial and clinical assessment of the […]

Posted on by — Leave a comment

Osteogenesis Imperfecta Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Mereo BioPharma, Amgen Pharmaceuticals

“Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the 7MM. The Osteogenesis Imperfecta market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various […]

Posted on by — Leave a comment

Bone Graft Harvester Market is Driven by 8.6% CAGR to Hit US$ 555.3 Million by 2024-2030 | Key Players: Arthrex, Acumed, Globus Medical, Zimmer Biomet, Paragon, Paradigm BioDevices, Anthogyr SAS

Bone Graft Harvester Market Set to Exceed US$ 555.3 Million by 2030, Driven by Growing Prevalence of Bone Disorders The Bone Graft Harvester Market is poised to achieve a valuation of US$ 555.3 million by 2030, fueled by a remarkable Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period from 2024 to 2030. […]

Posted on by — Leave a comment

Less Surgery, More Recovery: Here is How Regenerative Medicine is Shaping the Future for Neurosurgeons

Dr. Abdul Baker is a renowned Neurosurgeon specializing in advanced and minimally invasive spine surgery, an expert in robotic surgery he currently practices from 2 clinics he established in Texas, with visiting practices in Dubai and Abu Dhabi in the UAE. Dr. Baker, a renowned neurosurgeon in Dallas, Texas, is pioneering regenerative medicine in neurosurgery, […]

Posted on by — Leave a comment

Post-Traumatic Stress Disorder Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Merck KGaA, Pfizer Inc.

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Post-Traumatic Stress Disorder pipeline constitutes 20+ key companies continuously working towards developing 22+ PTSD treatment therapies, analysis of Clinical Trials, Therapies, MOA, ROA, and Developments analyzes DelveInsight. The Post-Traumatic Stress Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]